JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M110709200 on November 9, 2001

J. Biol. Chem., Vol. 277, Issue 6, 4223-4231, February 8, 2002
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/6/4223    most recent
M110709200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Di Lullo, G. A.
Right arrow Articles by San Antonio, J. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Di Lullo, G. A.
Right arrow Articles by San Antonio, J. D.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Mapping the Ligand-binding Sites and Disease-associated Mutations on the Most Abundant Protein in the Human, Type I Collagen*

Gloria A. Di LulloDagger , Shawn M. Sweeney§, Jarmo Körkkö, Leena Ala-Kokko||, and James D. San AntonioDagger §**

From the Dagger  Department of Medicine and the Cardeza Foundation for Hematologic Research and the § Department of Pathology, Anatomy and Cell Biology, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, the  Center of Gene Therapy and Department of Medicine, Tulane University Health Sciences Center, New Orleans, Louisiana 70112, and the || Collagen Research Unit, Biocenter and Department of Medical Biochemistry, University of Oulu, 90220 Oulu, Finland

Type I collagen is the most abundant protein in humans, and it helps to maintain the integrity of many tissues via its interactions with cell surfaces, other extracellular matrix molecules, and growth and differentiation factors. Nearly 50 molecules have been found to interact with type I collagen, and for about half of them, binding sites on this collagen have been elucidated. In addition, over 300 mutations in type I collagen associated with human connective tissue disorders have been described. However, the spatial relationships between the known ligand-binding sites and mutation positions have not been examined. To this end, here we have created a map of type I collagen that includes all of its ligand-binding sites and mutations. The map reveals the existence of several hot spots for ligand interactions on type I collagen and that most of the binding sites locate to its C-terminal half. Moreover, on the collagen fibril some potentially relevant relationships between binding sites were observed including the following: fibronectin- and certain integrin-binding regions are near neighbors, which may mechanistically relate to fibronectin-dependent cell-collagen attachment; proteoglycan binding may potentially impact upon collagen fibrillogenesis, cell-collagen attachment, and collagen glycation seen in diabetes and aging; and mutations associated with osteogenesis imperfecta and other disorders show apparently nonrandom distribution patterns within both the monomer and fibril, implying that mutation positions correlate with disease phenotype. These and other observations presented here may provide novel insights into evaluating type I collagen functions and the relationships between its binding partners and mutations.


* This work was supported by National Institutes of Health Grant HL-53590 and American Heart Association Grant 9910067U (to J. S. A.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

** To whom correspondence should be addressed: Cardeza Foundation, Thomas Jefferson University, Rm. 813 Curtis, 1015 Walnut St., Philadelphia, PA 19107. Tel.: 215-955-6121; Fax: 215-923-3836; E-mail: james.sanantonio@mail.tju.edu.


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
S. M. Sweeney, J. P. Orgel, A. Fertala, J. D. McAuliffe, K. R. Turner, G. A. Di Lullo, S. Chen, O. Antipova, S. Perumal, L. Ala-Kokko, et al.
Candidate Cell and Matrix Interaction Domains on the Collagen Fibril, the Predominant Protein of Vertebrates
J. Biol. Chem., July 25, 2008; 283(30): 21187 - 21197.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Giudici, N. Raynal, H. Wiedemann, W. A. Cabral, J. C. Marini, R. Timpl, H. P. Bachinger, R. W. Farndale, T. Sasaki, and R. Tenni
Mapping of SPARC/BM-40/Osteonectin-binding Sites on Fibrillar Collagens
J. Biol. Chem., July 11, 2008; 283(28): 19551 - 19560.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. M. Humphries, Y. Lu, E. G. Canty, and K. E. Kadler
Active Negative Control of Collagen Fibrillogenesis in Vivo: INTRACELLULAR CLEAVAGE OF THE TYPE I PROCOLLAGEN PROPEPTIDES IN TENDON FIBROBLASTS WITHOUT INTRACELLULAR FIBRILS
J. Biol. Chem., May 2, 2008; 283(18): 12129 - 12135.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Perumal, O. Antipova, and J. P. R. O. Orgel
Collagen fibril architecture, domain organization, and triple-helical conformation govern its proteolysis
PNAS, February 26, 2008; 105(8): 2824 - 2829.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Makareeva, E. L. Mertz, N. V. Kuznetsova, M. B. Sutter, A. M. DeRidder, W. A. Cabral, A. M. Barnes, D. J. McBride, J. C. Marini, and S. Leikin
Structural Heterogeneity of Type I Collagen Triple Helix and Its Role in Osteogenesis Imperfecta
J. Biol. Chem., February 22, 2008; 283(8): 4787 - 4798.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Makareeva, W. A. Cabral, J. C. Marini, and S. Leikin
Molecular Mechanism of {alpha}1(I)-Osteogenesis Imperfecta/Ehlers-Danlos Syndrome: UNFOLDING OF AN N-ANCHOR DOMAIN AT THE N-TERMINAL END OF THE TYPE I COLLAGEN TRIPLE HELIX
J. Biol. Chem., March 10, 2006; 281(10): 6463 - 6470.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. K. Thomas, M. Nakamura, D. Wienke, C. M. Isacke, A. Pozzi, and P. Liang
Endo180 Binds to the C-terminal Region of Type I Collagen
J. Biol. Chem., June 17, 2005; 280(24): 22596 - 22605.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. V. Persikov, J. A. M. Ramshaw, and B. Brodsky
Prediction of Collagen Stability from Amino Acid Sequence
J. Biol. Chem., May 13, 2005; 280(19): 19343 - 19349.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Brittingham, M. Colombo, H. Ito, A. Steplewski, D. E. Birk, J. Uitto, and A. Fertala
Single Amino Acid Substitutions in Procollagen VII Affect Early Stages of Assembly of Anchoring Fibrils
J. Biol. Chem., January 7, 2005; 280(1): 191 - 198.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. M. Tam, T. R. Moore, G. S. Butler, and C. M. Overall
Characterization of the Distinct Collagen Binding, Helicase and Cleavage Mechanisms of Matrix Metalloproteinase 2 and 14 (Gelatinase A and MT1-MMP): THE DIFFERENTIAL ROLES OF THE MMP HEMOPEXIN C DOMAINS AND THE MMP-2 FIBRONECTIN TYPE II MODULES IN COLLAGEN TRIPLE HELICASE ACTIVITIES
J. Biol. Chem., October 8, 2004; 279(41): 43336 - 43344.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
T. Yoneyama, H. Kasuya, H. Onda, H. Akagawa, K. Hashiguchi, T. Nakajima, T. Hori, and I. Inoue
Collagen Type I {alpha}2 (COL1A2) Is the Susceptible Gene for Intracranial Aneurysms
Stroke, February 1, 2004; 35(2): 443 - 448.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Baronas-Lowell, J. L. Lauer-Fields, and G. B. Fields
Induction of Endothelial Cell Activation by a Triple Helical {alpha}2{beta}1 Integrin Ligand, Derived from Type I Collagen {alpha}1(I)496-507
J. Biol. Chem., January 9, 2004; 279(2): 952 - 962.
[Abstract] [Full Text] [PDF]


Home page
Biophys. JHome page
C. Gaudet, W. A. Marganski, S. Kim, C. T. Brown, V. Gunderia, M. Dembo, and J. Y. Wong
Influence of Type I Collagen Surface Density on Fibroblast Spreading, Motility, and Contractility
Biophys. J., November 1, 2003; 85(5): 3329 - 3335.
[Abstract] [Full Text] [PDF]


Home page
Protein Sci.Home page
I. Majsterek, E. McAdams, E. Adachi, S. T. Dhume, and A. Fertala
Prospects and limitations of the rational engineering of fibrillar collagens
Protein Sci., September 1, 2003; 12(9): 2063 - 2072.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. M. Sweeney, G. DiLullo, S. J. Slater, J. Martinez, R. V. Iozzo, J. L. Lauer-Fields, G. B. Fields, and J. D. S. Antonio
Angiogenesis in Collagen I Requires {alpha}2{beta}1 Ligation of a GFP*GER Sequence and Possibly p38 MAPK Activation and Focal Adhesion Disassembly
J. Biol. Chem., August 15, 2003; 278(33): 30516 - 30524.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. L. Lindsey, J. Yoshioka, C. MacGillivray, S. Muangman, J. Gannon, A. Verghese, M. Aikawa, P. Libby, S. M. Krane, and R. T. Lee
Effect of a Cleavage-Resistant Collagen Mutation on Left Ventricular Remodeling
Circ. Res., August 8, 2003; 93(3): 238 - 245.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Meyer, L. Notari, and S. P. Becerra
Mapping the Type I Collagen-binding Site on Pigment Epithelium-derived Factor. IMPLICATIONS FOR ITS ANTIANGIOGENIC ACTIVITY
J. Biol. Chem., November 15, 2002; 277(47): 45400 - 45407.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.